VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,530 | -10.6% | 94 | 0.0% | 0.00% | – |
Q2 2023 | $2,830 | -68.0% | 94 | -65.7% | 0.00% | – |
Q1 2023 | $8,856 | +52.4% | 274 | +35.0% | 0.00% | – |
Q4 2022 | $5,811 | -73.6% | 203 | -77.9% | 0.00% | -100.0% |
Q3 2022 | $22,000 | -99.2% | 918 | -99.1% | 0.00% | -98.7% |
Q2 2022 | $2,720,000 | -20.0% | 99,359 | +12.1% | 0.08% | -9.2% |
Q1 2022 | $3,399,000 | -11.8% | 88,640 | -26.3% | 0.09% | -11.2% |
Q4 2021 | $3,854,000 | +5.5% | 120,331 | -2.9% | 0.10% | -3.9% |
Q3 2021 | $3,653,000 | -15.0% | 123,943 | -2.0% | 0.10% | -19.0% |
Q2 2021 | $4,297,000 | +1.2% | 126,459 | -3.2% | 0.13% | -8.7% |
Q1 2021 | $4,244,000 | +32546.2% | 130,581 | +38419.5% | 0.14% | +13700.0% |
Q4 2020 | $13,000 | 0.0% | 339 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $13,000 | -99.7% | 339 | -99.7% | 0.00% | -99.5% |
Q2 2020 | $4,617,000 | +230750.0% | 125,875 | +144583.9% | 0.21% | – |
Q1 2020 | $2,000 | -99.5% | 87 | -99.3% | 0.00% | -100.0% |
Q4 2019 | $391,000 | +32.1% | 13,366 | +20.7% | 0.02% | +21.4% |
Q3 2019 | $296,000 | -69.8% | 11,071 | -71.2% | 0.01% | -72.0% |
Q2 2019 | $981,000 | +23.1% | 38,384 | +8.0% | 0.05% | -3.8% |
Q1 2019 | $797,000 | +75.2% | 35,531 | +64.5% | 0.05% | +92.6% |
Q4 2018 | $455,000 | +8.3% | 21,593 | -4.8% | 0.03% | +22.7% |
Q3 2018 | $420,000 | -22.9% | 22,686 | -7.1% | 0.02% | -24.1% |
Q2 2018 | $545,000 | 0.0% | 24,431 | -1.5% | 0.03% | -3.3% |
Q1 2018 | $545,000 | -9.2% | 24,804 | -3.9% | 0.03% | -14.3% |
Q4 2017 | $600,000 | +6.8% | 25,823 | +5.5% | 0.04% | -2.8% |
Q3 2017 | $562,000 | +13.5% | 24,466 | +9.2% | 0.04% | +2.9% |
Q2 2017 | $495,000 | -13.9% | 22,401 | -11.2% | 0.04% | -20.5% |
Q1 2017 | $575,000 | +71.6% | 25,217 | +57.4% | 0.04% | +51.7% |
Q4 2016 | $335,000 | -5.9% | 16,021 | +19.0% | 0.03% | -17.1% |
Q3 2016 | $356,000 | +92.4% | 13,462 | +101.6% | 0.04% | +75.0% |
Q2 2016 | $185,000 | – | 6,677 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |